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Adult humans fail to regenerate their hearts following injury, and this failure to regenerate myocardium is a
leading cause of heart failure and death worldwide. Although all adult mammals appear to lack significant
cardiac regeneration potential, some vertebrates can regenerate myocardium throughout life. In addition,
new studies indicate that mammals have cardiac regeneration potential during development and very
soon after birth. The mechanisms of heart regeneration among model organisms, including neonatal
mice, appear remarkably similar. Orchestrated waves of inflammation, matrix deposition and remodeling,
and cardiomyocyte proliferation are commonly seen in heart regeneration models. Understanding why
adult mammals develop extensive scarring instead of regeneration is a crucial goal for regenerative
biology.Introduction
The intricate process of regeneration restores tissue architecture
through a sequential orchestration of events including cellular
proliferation, differentiation and dedifferentiation, and coordi-
nated morphogenic rearrangements. In a vital organ like the
heart, regeneration is not only fascinating but also clinically rele-
vant. Lower vertebrates such as the newt and zebrafish have an
astonishing ability to replace lost cardiac tissue (Gamba et al.,
2014; Poss et al., 2002; Witman et al., 2011), but there has
been a longstanding dogma that mammalian heart tissue could
never regenerate, reinforced by the belief that adult mammalian
cardiac cells are incapable of cell division. In response to cardiac
injury, adult mammals, including humans, fail to regenerate the
majority of the lost cardiomyocytes and instead replace necrotic
muscle with scar tissue. The loss of cardiomyocytes eventually
compromises contractility of the remaining myocardium, leading
to heart failure and death when the extent of injury is severe (Por-
rello and Olson, 2014). However, recent data indicate that
mammalian cardiogenesis occurs during adult life, including in
humans (Bergmann et al., 2009, 2015). In addition, the neonatal
mouse heart has a regenerative response immediately after birth
(Porrello et al., 2011a). Thus, regeneration of myocardial tissue is
an exciting therapeutic goal. We are far from a complete under-
standing of how heart tissue can regenerate, but we are now
defining molecular mechanisms that could open the door to
stimulating adult mammalian heart regeneration.
Heart Regeneration in Lower Vertebrates
Teleosts
Teleost fish can effectively regenerate many body parts in-
cluding brain (Kroehne et al., 2011), retina (Vihtelic and Hyde,
2000), fins (Johnson and Weston, 1995), spinal cord (Becker
et al., 1997), and heart (Poss et al., 2002). Availability of genetic
and molecular tools as well as the extensive regenerative capa-
bility even into adulthood havemade the zebrafish the best char-
acterized heart regeneration model system to date. Teleosts
have two-chambered hearts that pump blood to the body and
the gills. As shown in seminal studies by Poss and colleagues362 Developmental Cell 36, February 22, 2016 ª2016 Elsevier Inc.(Lepilina et al., 2006; Poss et al., 2002), within seconds after
resection of the zebrafish ventricular apex, profuse bleeding
from the ventricle is stopped by clotting in the wound. Following
fibrin deposition, the zebrafish heart does not go through the
intense collagen deposition and scarring seen in mammalian
hearts after injury. Instead, cells proliferate to replace lost cardi-
omyocyte tissue. The proliferation in cardiomyocytes peaks at
14 days post resection. By 60 days post resection, almost all
the lost muscle tissue is replaced, with the contractile function
of hearts appearing grossly normal (Kikuchi and Poss, 2012;
Poss et al., 2002). Studies in zebrafish have not supported
stem cells as the source of regenerating myocardium. Cre-
based genetic fate mapping has shown that pre-existing cardio-
myocytes reduce organization of their sarcomeric structures and
dedifferentiate to a more embryonic form, followed by cell divi-
sion and maturation that recapitulates the developmental pro-
gram (Jopling et al., 2010; Kikuchi et al., 2010).
In addition to the apical resection approach, zebrafish
myocardial injury can also be achieved through genetic abla-
tion(Wang et al., 2011) and cryoinjury (Chablais et al., 2011; Gon-
za´lez-Rosa et al., 2011; Schnabel et al., 2011) (Figure 1). Robust
myocardial regeneration is observed in both cases, although the
dynamics of the regenerative process may differ. In the genetic
ablation experiments by Wang et al. (2011), cardiomyocyte-spe-
cific Cre recombinase activity from the cmlc2 promoter drove the
expression of a cytotoxic DTA (diphtheria toxin A chain) gene
that led to cardiomyocyte death. When more than 60% of cardi-
omyocytes were eliminated with this technique, tissue was re-
placed through regeneration with minimal scarring and restored
function (Wang et al., 2011). In cryocauterization (or cryoinjury),
the heart was probed with a flash-frozen metal filament, causing
local but massive death of cardiomyocytes (approximately 25%
of ventricular muscle) as well as other cell types (Chablais et al.,
2011). In the cryoinjury model, the course of healing includes an
initial deposit of collagen that is later cleared, and the heart mus-
cle renews itself 130 days after cryoinjury (Gonza´lez-Rosa et al.,
2011). It is possibly due to the clearing of the necrotic tissue
that the cryoinjury injury model follows a different timeline and
Figure 1. Cardiac Regeneration across
Model Organisms: Regenerative Capacity of
the Heart Varies Depending on the
Organism and Type of Injury
Cardiac regeneration has been studied in a num-
ber of model systems. While lower vertebrate
model species such as teleost fish and urodeles
retain regenerative capacity throughout adult life,
anurans and mammals lose this ability in adult-
hood. It should be noted that not all teleost fish
have been reported to have complete regenerative
response upon heart injury. Future studies on
different species and different injury types will
broaden our understanding of evolutionary con-
servation of capacity for cardiac regeneration.
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all three injury models, the zebrafish heart is able to regain func-
tional as well as physical integrity.
It should be noted that while organ regeneration studies in tel-
eosts have not been limited to zebrafish (Nabrit, 1929), heart
regeneration in medaka, another teleost model species, have re-
vealed differential reparative phenotypes: medaka fish failed to
regenerate its heart upon injury and responded with excessive
fibrosis (Ito et al., 2014). Future studies need to investigate
whether regenerative capacity differs with age or injury type in
different teleost species.
Urodeles
Urodeles including newts and salamanders have been regarded
as the champions of regeneration due to their extensive ability toDevelopmental Cell 36,replace body parts after amputation or
injury of different tissues, including the
lens, jaw, limbs, tail, and heart (Faber,
1960; Suetsugu-Maki et al., 2012). The
phenomenon of limb regeneration in sala-
manders was described in 1769 (Spallan-
zani, 1769), and classical experiments by
Paul Weiss and colleagues in the 1930s in
the regenerating urodele limb described
the kinetics of regeneration (Weiss and
Walker, 1934). Many processes that
were initially characterized in urodele
limb and tail regeneration, such as wound
healing and innervation, have now been
shown to play a role in heart regeneration
across multiple species.
The newt and aquatic axolotl hearts
have two atria and a single avascular
ventricle. Following axolotl or newt heart
injury, the heart can replace lost tissue
and function within 90 days without evi-
dence of scarring (Becker et al., 1974;
Flink, 2002; Oberpriller and Oberpriller,
1974). Regeneration in the urodele heart
starts with the formation of a clot to pre-
vent blood loss, followed by fibrin and
collagen deposits at 7 days post injury
(Witman et al., 2011). Gene expression
changes associatedwith increased extra-
cellular matrix (ECM) are prominent re-sponses to cardiac injury; matrix metalloproteinases, collagen,
keratin, tenascin-C, and other ECM components are expressed
immediately and serve to provide a structural framework for the
regeneration (Gamba et al., 2014; Piatkowski et al., 2013).
Cellular proliferation increases in the epicardium and cardiomyo-
cytes (both atrial and ventricular) (Flink, 2002), andwithin the next
50 days the matrix deposition is gradually replaced with cardio-
myocytes (Witmanet al., 2011). Interestingly, distinct populations
of cells in the regenerate have been identified to express Islet1
and Gata4, which are markers for cardiac progenitors (Witman
et al., 2011), suggesting recapitulation of developmental cardio-
genesis during regeneration. Notably, Laube et al. (2006) showed
that the newt myocardium downregulates expression of sarco-
meric genes during regeneration, supporting the hypothesisFebruary 22, 2016 ª2016 Elsevier Inc. 363
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during regeneration. After 60–90 days, the tissue is regenerated
completely without scarring (Witman et al., 2011); however, the
robustness of the regenerative response and degree of scarring
can vary depending on the location and size of the resected tis-
sue (Kikuchi and Poss, 2012; Witman et al., 2011).
Anurans
Anurans are an order of Amphibians distinct from urodeles and
includes toads and frogs. In the late 1960s and the early
1970s, the Soviet scientist Rumyantsev characterized cellular
proliferation and ultrastructure of muscle fibers following heart
injury in adult frogs (Rumjancev and Carlson, 1991; Rumyantsev,
1973). Adult anuran cardiomyocytes are capable of DNA synthe-
sis, cellular proliferation, and dedifferentiation to some extent,
but fail to carry out complete heart regeneration, leading to for-
mation of scar tissue in the injured frog heart (Rumjancev and
Carlson, 1991; Rumyantsev, 1973).
There is a remarkable difference in the regenerative capacity
of the heart in anuran and urodele species of Amphibia. Anurans
lose their overall regenerative capacity progressively as they go
through metamorphosis from the larvae stage to the adult,
concomitant with maturation of the immune system (Izutsu and
Yoshizato, 1993; Rollins-Smith, 1998). Urodeles, which have
strikingly different immune systems compared with anurans,
also go through metamorphosis, but their immune system is
more stable (Godwin and Rosenthal, 2014). The differences in
regenerative capacity and adaptive immunity in adult anurans
and urodeles may be mechanistically related. In specificity,
speed of onset, and memory, the adult frog immune system is
more comparable with mammals (Godwin and Rosenthal,
2014). Salamanders, on the other hand, are considered to have
subdued immune systems; the humoral response is relatively
slow, and despite a large T cell and B cell repertoire, the immune
memory of salamanders is low (Tournefier et al., 1998). These
observations are consistent with the concept that the immune
system is critical for the regenerative response in myocardium,
as discussed below.
Heart Regeneration in Rodents
Cardiac Regeneration in the Fetal Mouse Heart
While cardiac development and postnatal heart regeneration
have been extensively studied, a remarkable study by Drenck-
hahn et al. (2008) explored the regenerative capacity of the heart
during development. A cardiomyocyte-lethal mutant gene in the
X chromosome was conditionally expressed at embryonic day
12.5 (E12.5) in only half of the cardiomyocytes in female embryos
due to random X inactivation. Fetal hearts that had undergone
this genetic ablation were able to restore approximately 50%
of lost cardiomyocyte mass, indicating that the embryonic
environment and the transcriptional state of embryonic cardio-
myocytes facilitate cardiomyocyte cell-cycle re-entry and repo-
pulation of the heart (Figure 2). This highlights the importance of
understanding the dramatic change in cardiac regenerative po-
tential from the embryo through the first weeks of life.
Cardiac Regeneration in Neonatal Mammals
Adult mammalian hearts fail to show significant regenerative ca-
pacity in different injury models (Kikuchi and Poss, 2012; Ru-
myantsev, 1977), but the possibility of a regenerative window
in children has been proposed for almost a century in analyses364 Developmental Cell 36, February 22, 2016 ª2016 Elsevier Inc.of postmortem histological specimens (Macmahon, 1937; War-
thin, 1924). These studies inspired Robledo (1956) to explore
cardiac regeneration in young rats in the 1950s, but he observed
only incomplete regeneration following a myocardial burn injury
in rats in day 4–7 after birth. More recently, case reports from
corrective heart surgeries in infants (Fratz et al., 2011) and
myocardial infarction (MI) of a newborn child (Haubner et al.,
2015) have suggested that human neonatal heart can also
functionally recover and may have a higher regenerative
potential. Recently, direct experimental evidence for a robust
regenerative capacity in neonates has been reported in mice in
a range of injury models including ventricular resection (Porrello
et al., 2011a), MI (Haubner et al., 2012), cryoinfarction (Jesty
et al., 2012; Strungs et al., 2013), and clamping (Bryant et al.,
2014).
Neonatal heart regeneration studies in mice were reported by
Porrello et al. (2011a, 2013) in resection and MI models. These
studies identified a time window immediately after birth when
the mammalian heart mounts a robust regenerative response.
Neonatal animals that have undergone resection or MI surgery
exhibit increased cardiomyocyte proliferation and robust angio-
genic growth. Although some scarring may occur, substantial
lost tissue is restored within 3 weeks, in both MI and the ventric-
ular resection model when 15% of the ventricular apex is re-
sected (Porrello et al., 2011a). Similar to the regenerative
response in teleosts and axolotls, the neonatal mouse injury
response is initiated with rapid clotting, inflammatory cell infiltra-
tion to the injury site, epicardial activation, and initiation of cardi-
omyocyte proliferation. In the MI model, ischemia is routinely
induced by ligation of the left anterior descending coronary ar-
tery soon after birth. Although the infarction model initially in-
duces myocyte necrosis and collagen deposition, 95% of lost
tissue is replaced within 3 weeks with minimal fibrosis, and car-
diac function is normal 9 months after surgery (Porrello et al.,
2013). Genetic fate mapping by Porrello et al. (2013) and others
has shown that the major source of cardiomyocyte repopulation
is pre-existing cardiomyocytes that re-enter the cell cycle (Haub-
ner et al., 2012), as in zebrafish (Jopling et al., 2010; Lepilina
et al., 2006). Interestingly, this robust regenerative response is
not elicited in mice injured at postnatal day 7 or day 14, revealing
that soon after birth there is a sharp decline in heart regenerative
potential.
Controversy arose in the field when Andersen et al. (2014) re-
ported extensive scarring and limited regeneration following
neonatal ventricular resection. Bryant et al. (2014) conducted a
systemic analysis of technical considerations in the surgery
and demonstrated that experimental issues such as the size of
apical resection can lead to variations in the regenerative
response, including some degree of scarring at 21 days post
operation. There is clear evidence for myocardial regeneration
after ventricular resection in neonatal mice as demonstrated by
several independent groups (Bryant et al., 2014; Han et al.,
2015; Porrello et al., 2011a), although technical issues can affect
the regenerative response. In contrast, cardiomyocyte prolifera-
tion in neonatal mice does not increase significantly following
cryoinjuries, and transmural cryoinjury fails to elicit regenerative
response, while non-transmural cryoinjury models can fully
recover (Darehzereshki et al., 2015). This underscores the impor-
tance of carefully controlled experiments with consistent choice
Figure 2. Mammalian Response to Injury:
Cardiac Regeneration Has Been Explored in
Fetal, Neonatal, and Adult Mammals and
Occurs to a Different Extent in Each Model
At embryonic stages, compensatory growth in
cardiomyocytes restores up to 50% of lost tissue.
In the neonatal mouse, tissue can replace a ma-
jority of lost cardiomyocytes with minimal scarring
in myocardial infarction and ventricular resection
models. In the adult mouse, cardiomyocyte pro-
liferation is insufficient to replace lost tissue, and
extracellular matrix deposition following injury
leads to extensive scarring.
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mouse heart regeneration experiment.
Evolutionarily Conserved Mechanisms in Heart
Regeneration
Sources of Regenerated Myocardium
An explosion of interest in adult stem cell biology over the past 15
years has driven interest in the concept that adult stem cells acti-
vated following injury can be a source of new cardiomyocytes.
However, as described above, fate mapping studies in zebrafish
heart regeneration reveal that fishmyocardium replaces lost car-
diomyocytes through proliferation of existing cardiomyocytes. InDevelopmental Cell 36,two independent studies (Jopling et al.,
2010; Kikuchi et al., 2010), inducible Cre
recombinase (CreER) expression was
driven by the cardiac myosin light chain
2 (cmlc2) promoter sequence, resulting
in the expression of a loxP flanked EGFP
reporter gene. Before cardiac injury,
all cardiomyocytes expressing Cmlc2
were labeled by EGFP expression, and
30 days post ventricular resection,
the majority of the regenerated tissue
was labeled with EGFP expression,
showing that cmlc2+ cardiomyocytes
were the major source for regenerated
myocardium.
A study from Poss and colleagues
further dissected the contribution from
subpopulations of cardiac muscle into
the regenerate (Gupta and Poss, 2012).
The authors employed a multicolor clonal
analysis system in order to identify three
distinct muscle lineages in the zebrafish
heart: primordial, trabecular, and cortical
muscle, distinct in their order of develop-
ment during cardiac morphogenesis. The
multicolor clonal analysis technique em-
ployed in this study was adapted from
the Brainbow technology that was initially
developed in the mouse (Livet et al.,
2007). Cre/lox recombination was used
to create a stochastic gene expression
pattern from three tandem fluorophores,
allowing clones from a specific recombi-
nation event to be distinguished (Guptaand Poss, 2012). Clonal labeling in zebrafish cardiomyocytes re-
vealed that during regeneration, proliferation of cortical muscle
in the wound area is detectable at 14 days post amputation
and constitutes the primary component of the regenerate wall,
whereas the primordial layer of muscle is first detected at
30 days post amputation in a restricted lateral expansion, as
observed during embryogenesis. However, the appearance of
muscle layers during regeneration is in reverse order to the order
in cardiac development (Gupta and Poss, 2012).
Comparable fatemapping analysis has also been performed in
the neonatal mouse (Senyo et al., 2013). Using genetic fate map-
ping and stable isotope imaging technology, Senyo et al. (2013)February 22, 2016 ª2016 Elsevier Inc. 365
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mouse, new cardiomyocytes arise from pre-existing cardiomyo-
cytes. In addition, after injury, modest new cardiomyocyte
regeneration near the injury increased, and these myocytes
appeared to arise from pre-existing cardiomyocytes. A recent
study by Kimura et al. (2015) reported fate mapping of cycling
cardiomyocytes following injury to a subset of hypoxic cardio-
myocytes that express HIF1-a. The extent to which a progenitor
cell pool contributes to cardiomyocyte renewal remains con-
troversial: c-kit+ cells were previously reported to mark cardio-
myocyte progenitors (Angert et al., 2011; Beltrami et al., 2003;
Hatzistergos et al., 2010; Orlic et al., 2001) but a quantitatively
rigorous genetic fate mapping study showed that this contribu-
tion is functionally negligible (van Berlo et al., 2014). Hatzistergos
et al. (2015) reported that c-kit+ cells are of cardiac neural crest
origin in development, and their limited contribution to cardiac
progenitors is due to a nonpermissive environment in the devel-
oping heart. In contrast, a new study of multiple lines of geneti-
cally engineered mice showed no significant cardiogenesis
from c-kit+ cells, consistent with van Berlo et al.’s study (Sultana
et al., 2015). The role of c-kit+ cells in post-infarction myogenesis
was explored in 2012 by Jesty et al. (2012), who reported that
c-kit+ cells partially support repopulation of the myocardium
following injury in the neonatal heart, but that c-kit+ cells do
not adopt cardiomyocyte cell fate during myogenic repair in
adult mice that harbor a transcription marker for ckit (ckitBAC-
EGFP).
A major difference between lower vertebrates, such as the ze-
brafish and newt, and mammals may be their ability to complete
the cell cycle. In contrast to the mononucleated zebrafish cardi-
omyocytes that can re-enter the cell cycle in adulthood, many of
the cardiomyocytes in the mammalian heart become binucle-
ated either before (Jonker et al., 2007) or shortly after birth (Soon-
paa et al., 1996). In rodents, up to 95% of cardiomyocytes
are binucleated (Soonpaa et al., 1996), while binucleation is
much lower in human cardiomyocytes at 30%–40% (Mollova
et al., 2013). A study by Bersell et al. (2009) showed that
Neuregulin1 can induce proliferation of differentiated adult
cardiomyocytes in cell culture and in vivo. Interestingly, Neure-
gulin1 (NRG1) appears to affect the mononucleated subpopula-
tion of differentiated cardiomyocytes, supporting the premise
that mononucleated cardiomyocytes may be more receptive
to cell-cycle re-entry. However, D’Uva et al. (2015) recently
showed that cytokinesis in binucleated cardiomyocytes are
also possible with constitutive activation of the NRG1 co-recep-
tor ERBB2.
The Curious Role of Nerves
Over the last century, studies across multiple species have
shown that nerves are indispensable for regeneration inmany or-
gans. Classical experiments in newt limbs show that denervated
limbs cannot regenerate (Todd, 1823). Newt and salamander
lens, retina, and tail are other systems where adequate numbers
of nerve fibers are required to guide regeneration To date,
several nerve-derived factors have been shown to function in
regeneration, including fibroblast growth factors (FGFs) in verte-
brate limb regeneration (Gospodarowicz and Mescher, 1980),
glial growth factor in zebrafish tail regeneration and vertebrate
limb regeneration (Rojas-Mun˜oz et al., 2009; Wang et al.,
2000), nAG in newt limb regeneration (Kumar et al., 2007), and366 Developmental Cell 36, February 22, 2016 ª2016 Elsevier Inc.glial-derived neurotrophic factor in hematopoietic regeneration
in mammals (Lucas et al., 2013).
Recently, the role of nerves in heart regeneration has also been
explored. Mahmoud et al. (2015) mechanically interrupted the
left vagus nerve and found that this suppresses the heart regen-
erative response upon injury in neonatal mice. This suggests a
role for parasympathetic nerve function in heart regeneration.
In another recent study,White et al. (2015) explored the influence
of sympathetic nerves in cardiac regeneration. Mice that un-
dergo chemical sympathectomy have inhibited sympathetic re-
growth and failed cardiac regeneration following apical resection
surgery. These new findings suggest that nerves may function
in the regenerative process, although this does not appear
restricted to sympathetic versus parasympathetic nerves. It is
possible that a critical density of nerve factors is necessary to
support regeneration. The concept of a critical nerve density
rather than specific nerve synaptic activity in driving regeneration
is consistent with findings in axolotl limb regeneration (Kumar
and Brockes, 2012; Kumar et al., 2007; Litwiller, 1938). Thus,
regulation of the regenerative response in many tissues by
nerves appears to be an evolutionarily conserved pathway
among different species including lower vertebrates, and the
study of nerves in cardiac regeneration could shed light on
conserved regenerative molecular pathways.
Inflammatory and Immune Response in Heart
Regeneration
Unlike embryonic development, tissue growth in regeneration is
initiated by an injury, and the inflammatory response to that injury
is a critical regulator of the regenerative process. Inflammation
can drive regeneration but can also inhibit it under some circum-
stances. Godwin et al. (2013) reported that following macro-
phage depletion, newt limb regeneration fails and leads to exten-
sive fibrosis. In contrast, evidence for the constraining effects of
a developed immune system on regeneration come from studies
of Xenopus limbs. As young Xenopus larvae transition into adult-
hood through metamorphosis, their immune system also passes
through gradual maturation; concomitantly, they lose their re-
generative capacity (Godwin and Rosenthal, 2014). Grow et al.
(2006) performed gene expression analysis comparing earlier
stage regeneration-competent Xenopus limbs and later stage
regeneration-incompetent Xenopus limbs and reported a higher
level of pro-inflammatory genes expression 1 day post amputa-
tion in the regeneration-incompetent limbs. Limb amputation ex-
periments in the developing Xenopus limb suggest that it is the
local inflammatory response subsequent to the wound formation
that exerts a constraining effect on the regenerative capacity
(Godwin and Rosenthal, 2014; King et al., 2012). Together, the
studies in frogs and salamanders show that the early inflamma-
tory response plays a crucial role in the initiation of regenerative
processes.
In both lower vertebrates and mammals, cardiac injury is also
associated with an initial wave of inflammation. The conse-
quences of the inflammatory/immune response is remodeling
through scarring in non-regenerating animals, versus remodeling
through cellular repopulation in regenerating animals. Infiltration
by inflammatory cells in injured heart peaks around 3 days post
amputation in zebrafish hearts (Lien et al., 2006). The inflamma-
tory system responds immediately to cardiac injury in all verte-
brate species studied (Kyritsis et al., 2012; Xin et al., 2013a). In
Figure 3. Evolutionarily Conserved Mechanisms of Cardiac Regeneration: Cardiomyocyte Proliferation Is Central to the Process of Cardiac
Regeneration, and Several Processes Have Been Shown toModulate Proliferation upon Injury in a Range of Organisms that are Capable of a
Complete Regenerative Response
An inflammatory response tightly regulates a fine balance between proliferation and repair. Extracellular matrix deposition following injury creates a permissive
environment for cellular proliferation and is influenced by signals from the epicardium following injury. Neoangiogenesis is triggered by FGF and PDGF signaling
and provides a supply of oxygen and nutrients to the regrowing tissue, and new studies emphasize the requirement of nerves in the regenerate.
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regeneration (Aurora et al., 2014), and injury-induced cardiac
proliferation is inhibited by immunosuppression (Han et al.,
2015). Acute inflammation is required for neonatal heart regener-
ation, and in the absence of interleukin 6 (IL-6), cardiomyocytes
fail to proliferate upon injury (Han et al., 2015).
The relationship observed in anurans between maturation of
the immune system and the decrease in regenerative capacity
has been explored in mammals in the context of postnatal
changes in the immune system and the loss of capacity for
cardiac regeneration (Aurora et al., 2014). Aurora et al. (2014)
identified differences in the cellular immune response to MI in
1-day-old and 14-day-old mice; they used a macrophage deple-
tion model in neonatal mice to show that macrophages are
required for regeneration and neoangiogenesis in the injured
heart. Interestingly, macrophage depletion did not influence
cardiomyocyte proliferation following infarction. The molecular
profiling of macrophages suggested that secretion of pro-angio-
genic cytokines may be responsible for their important role in
cardiac regeneration (Aurora et al., 2014) (Figure 3).
Angiogenesis and Heart Regeneration
Throughout phylogeny, the formation of new vasculature
following injury is vital for regeneration (Kleinheinz, 2013). As
new tissue with complex architecture is restored, the regenerat-
ing tissue needs a continuous supply of energy and substrates
as well as routes for eliminating metabolic products. Therefore,
a functioning dynamic vasculature is critical for a successful
regenerative response. In the absence of neovascularization
following injury, the zebrafish heart fails to regenerate and
instead forms extensive fibrotic scarring (Lepilina et al., 2006).Gene expression and genetic analyses in zebrafish have estab-
lished regulators of angiogenesis that are essential for the
response to cardiac injury. FGF receptor expression in the
epicardium and FGF ligand expression in the myocardium
appear to be required for the formation of new vasculature,
and this process is thought to regulate epithelial tomesenchymal
transition (EMT) of the epicardium in order to form coronary
vasculature (Lepilina et al., 2006). In addition, Pdgf signaling is
required for epicardial proliferation and new blood vessel forma-
tion in cardiac regeneration (Kim et al., 2010), suggesting that
new vascular formation during regeneration recapitulates the
molecular mechanisms that govern the developmental pro-
cesses of blood vessel formation. Interestingly, cxcr4a mutant
zebrafish that fail to develop coronary vasculature in themyocar-
dium can be viable as adults, but the mutants that survive into
adulthood fail to regenerate their hearts, suggesting loss of this
oxygen supply is especially critical for regeneration (Harrison
et al., 2015).
In neonatal mice, robust neovascularization is evident during
the regenerative response to either apical resection or MI in-
juries (Porrello et al., 2011a, 2013). In adult mice, when the regen-
erative response is not evident, the neovascular response is
also not observed, suggesting that lack of blood vessel forma-
tion after injury could contribute to loss of cardiac regenerative
capacity (Epelman et al., 2015; Lavine et al., 2014). Factors
inducing vascular regeneration have been shown to improve tis-
sue renewal and cardiac functional restoration in adult mice
following MI (Zangi et al., 2013). Zangi et al. (2013) have em-
ployed modified RNA (modRNA) technology to induce VEGF
expression in a spatiotemporally controlled manner and therebyDevelopmental Cell 36, February 22, 2016 ª2016 Elsevier Inc. 367
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neoangiogenesis.
Extracellular Matrix and Heart Regeneration
During normal cardiac development, signaling from the ECM
provides structure and guidance for cellular migration, prolifera-
tion, and differentiation. For example, fibronectin is a key cue for
migration of cardiomyocytes toward themidline (Trinh and Stain-
ier, 2004) and is a regulator of cardiomyocyte proliferation (Ieda
et al., 2009). Similarly, changes in the tissue microenvironment
are a crucial component of the regenerative response. In
neonatal mice and lower vertebrates, the myocardium goes
through an extensive remodeling process and scar formation is
minimized compared with adult mammalian myocardium, but
new ECM deposition is nevertheless considerable (Piatkowski
et al., 2013; Porrello et al., 2011a; Wang et al., 2013). Ablation
of transient scar formation in zebrafish through pharmacological
inhibition of transforming growth factor b signaling abolishes car-
diac regeneration (Chablais and Jazwinska, 2012). Studies in the
newt have revealed that an increase in ECM components pre-
cedes cardiomyocyte proliferation after injury, and that tenas-
cin-C is sufficient to induce proliferation in vitro (Mercer et al.,
2013). In the newt and zebrafish, ECM components and ECM-
modifying proteases are among the most robustly enriched
genes expressed in response to local injury; in contrast, in adult
mammalian myocardium, inflammation andmetabolic genes are
the most significantly enriched transcripts (Mercer et al., 2013).
Over several weeks following injury, regeneration-competent
hearts marginalize fibrotic ECM deposition to the periphery
and replace it with regenerated myocardium (Porrello et al.,
2013), as observed in newts and zebrafish (Gonza´lez-Rosa
et al., 2011; Mercer et al., 2013).
ECM components secreted from embryonic fibroblasts
include fibronectin, collagen, and heparin-binding EGF-like
growth factor, and these factors can promote cardiomyocyte
proliferation in a paracrine fashion (Ieda et al., 2009). Therefore,
it is possible that postnatal changes to ECM composition alter
the proliferative capacity of cardiomyocytes. Studies in zebrafish
have revealed that epicardium is especially important for initi-
ating ECM deposition (Wang et al., 2013); injury in the myocar-
dium induces epicardial cells to express fibronectin paralogs,
Fn1 and Fn1b, within a day of injury. Through genetic ablation
of fn1, Wang et al. (2013) showed that fibronectin is required
for heart regeneration, although not through the regulation of
cardiomyocyte proliferation.
Periostin is another secreted ECM component that has been
shown to increase cardiomyocyte cell-cycle activity (Ku¨hn
et al., 2007). While in development periostin plays a role in
EMT (Litvin et al., 2005), periostin is expressed in adult myocar-
dium upon injury (Butcher et al., 2007; Stanton et al., 2000). Pro-
moting collagen cross-linking in the ECM, periostin accelerates
fibrillogenesis and contributes to scar formation (Oka et al.,
2007). In a study by Ku¨hn et al. (2007) using the adult mouse
MI model, exogenous expression of periostin enhanced post-
injury myocardial proliferation and promoted cardiac repair,
which resulted in improvement in ventricular remodeling and
function. Periostin function was mediated through activation of
b-integrins on cardiomyocytes; in its absence, activation of
phosphatidylionsitol-3-OH kinase was sufficient for cell-cycle
re-entry (Ku¨hn et al., 2007). Controversy arose in the field when368 Developmental Cell 36, February 22, 2016 ª2016 Elsevier Inc.genetic manipulation of periostin did not alter cell-cycle activity,
cardiomyocyte content, or cardiac repair in mice, in either abla-
tion or overexpression (Lorts et al., 2009).
Cell type composition also appears to have importance in the
heart regenerative response due to their influence on the ECM.
Fibroblasts greatly influence the composition of ECMdeposition,
and their presence has been shown to affect the proliferative ca-
pacity of cardiomyocytes in vitro (Ieda et al., 2009). Fibroblasts
are more abundant in the adult mammalian heart compared
with fetal mammalian or adult non-mammalian hearts. Thus,
changes in fibroblast abundance or compositionmay be respon-
sible for the permissive versus nonpermissive cardiac environ-
ment for regenerative growth.
Development versus Regeneration in the Heart
Transcriptional Profile of Cardiomyocytes in
Development and Regeneration
A common principle observed in tissue regeneration is the
reactivation of the previously employed developmental tran-
scriptional programs. Studies in different model organisms
have shown that mechanisms in developmental cardiogenesis
also govern morphological regeneration of the injured heart.
As discussed previously, in lower vertebrates and mammals,
the source of new cardiomyocytes appears to be predomi-
nantly pre-existing cardiomyocytes that re-enter the cell cycle,
although a role for progenitors and stem cells remains hotly
debated in the cardiovascular community.
The cardiomyocyte lineage originates from mesodermal cells
that express T-box transcription factor Eomes and Mesp1 (Bon-
due et al., 2008), which is thought to be a regulator of cardiac
progenitor cell fate. These precursors are later allocated to two
major populations designated as the first heart field and the sec-
ond heart field, defined by their crescent shapes distinct on day
E7.5 in mouse embryogenesis. As the heart tube forms and then
loops to form the chambers, molecular cues further induce and
define mesodermal progenitors to different cardiac cell types.
An intricate gene regulatory network refines progenitor bound-
aries, terminal differentiation, and transcriptional identities spe-
cific to each cell type during heart organogenesis. At the early
stages of development, NKX2-5 and ISL1 expression define car-
diac progenitor cells (Cai et al., 2003; Ehrman and Yutzey, 1999).
This is followed by cardiomyocyte-specific expression of Hopx
in a subset of progenitors (Jain et al., 2015). Hopx defines cardi-
omyocyte cell fate and coordinates an antagonistic crosstalk be-
tween BMP and WNT pathways by physically interacting with
BMP effector SMADs to repress WNT genes (Jain et al., 2015)
and promote cardiomyogenesis. During cardiomyocyte differen-
tiation, zinc finger transcription factor GATA4 has an essential
role in the regulation of structural genes including a-myosin
heavy chain (a-mhc) and cardiac troponin C (Ctnc) (Molkentin
et al., 1997; Temsah and Nemer, 2005). Elucidation of the tran-
scriptional profile of cardiac progenitors has enabled derivation
of cardiomyocytes from embryonic stem cells (Qian et al.,
2012), and their therapeutic potential is being tested in grafts
into non-human primate models (Chong et al., 2014).
Reactivation of a GATA4-driven gene expression program
plays a role in the context of regeneration as well (Gupta et al.,
2013; Kikuchi et al., 2010), consistent with the observation that
the tissue activates an embryonic differentiation program for
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meric structures (Jopling et al., 2010). Another developmental
gene, Hand2, induces cardiomyocyte proliferation during regen-
eration (Schindler et al., 2014). Homeodomain transcription fac-
tor MEIS1, which is required for normal cardiac development
(Azcoitia et al., 2005; Stankunas et al., 2008), has been shown
to orchestrate postnatal cell-cycle arrest and maturation (Mah-
moud et al., 2013). Strikingly, deletion ofMeis1 in the adult heart
is sufficient to induce cardiomyocyte cell-cycle re-entry in adult
cardiomyocytes. In addition to activation of developmental
programs, expression of cardiac muscle genes and dedifferenti-
ation facilitate mitotic and morphogenetic activity during the
post-injury response in newt regeneration (Pesce et al., 2011).
Dedifferentiation has also been explored in mammalian cardio-
myocytes (Szibor et al., 2014), and many laboratories are now
trying to dissect the transcriptional program that renders adult
mammalian cardiomyocytes sufficiently dedifferentiated to be
more permissive for cell-cycle re-entry. Recently, an analysis
of global transcriptional programs in mammalian cardiomyocyte
differentiation and regeneration has revealed that the regener-
ating mouse heart reverses the transcriptional processes of
cardiomyocyte differentiation, with reactivation of latent devel-
opmental programs (O’Meara et al., 2015).
Disruption of the miRNA machinery in development and ho-
meostasis results in cardiac abnormalities (da Costa Martins
et al., 2008). A role for microRNAs (miRNA) in cardiomyocyte
proliferation and regeneration was revealed by numerous
studies including a study by Porrello et al. (2011b) and a fluores-
cent microscopy-based screen (Eulalio et al., 2012). MiRNAs are
short RNA sequences that base pair partially with mRNAs of
target genes and thereby regulate gene expression (Bartel,
2009). To date, dozens of miRNAs have been identified to play
critical roles in not just cardiomyocyte DNA synthesis and cyto-
kinesis but also postnatal mitotic arrest (Chen et al., 2013; Eulalio
et al., 2012; Porrello et al., 2011b; Wang et al., 2010; Yin et al.,
2012).
Epigenetic control of cardiogenesis has also gained consider-
able attention, particularly because epigenetic events regulate
the maintenance of the proliferative state of cardiomyocytes
through several mechanisms such as DNA methylation, chro-
matin remodeling, or covalent histone modifications including
acetylation and methylation. The chromatin remodeling BAF
complex and its subunit Baf60c have specific roles for transcrip-
tional regulation at cardiac-specific enhancer sites, and thus are
essential for cardiac morphogenesis (Lickert et al., 2004). Dele-
tion of histone deacetylase Hdac2 with Hopx during cardiogen-
esis results in increased cardiomyocyte proliferation, and this
effect is mediated through deacetylation of Gata4 (Trivedi
et al., 2010). Histone acetyltransferase P300 directly regulates
cardiac specification through Gata4, Mef2c, and Srf (Takaya
et al., 2008). Mice null for histone methyltransferase Smyd1 are
embryonic lethal, and mice deficient in histone demethylase
Jarid2 die immediately after birth (Gottlieb et al., 2002; Mysliwiec
et al., 2012). Interestingly, JARID2 directly represses Notch
target genes, thereby changing the responsiveness of cells to
the signaling events in the heart. Genetic deletion of Brahma-
related gene 1, an ATP-dependent chromatin-remodeling factor,
results in proliferation defects in myocardium (Hang et al., 2010).
Thus, epigenetic events in the heart are dynamic and directlycontrol cardiomyocytes and their proliferative state. Manipu-
lating the epigenetic state of cardiomyocytes during the critical
post-injury period is an attractive regenerative strategy, and his-
tone deacetylase inhibitors are potential therapeutic agents (Xie
and Hill, 2013).
Epicardium in Regeneration
The epicardium is the external epithelial layer that contributes to
myocardial growth through secretion of soluble growth factors.
For example, retinoic acid-mediated production of FGF ligands
and insulin-like growth factors (IGF) by epicardium drives growth
in the underlying myocardium during development (Lavine et al.,
2005; Li et al., 2011), thereby contributing to the morphogenesis
of the ventricles during development. Recent studies reveal that
epicardium participates in mitogen secretion during heart regen-
eration. Huang et al. (2013) reported that IGF signaling from the
epicardium is required for adequate cardiomyocyte proliferation
in zebrafish heart regeneration; the contribution of cells that are
gata4 lineage is impaired in regeneration when IGF signaling is
inhibited. This finding suggests that epicardium may participate
in initiation of the developmental gene program in adult cardio-
myocytes during post-injury remodeling of the heart. When the
epicardial cell population is genetically ablated in adult zebrafish,
cardiac proliferation is impaired and regeneration is delayed
(Wang et al., 2015).
Wei et al. (2015) reported that follistatin-like 1 (FSTL1) is an
epicardial cardiomyogenic factor that dramatically improves
regenerative repair and function upon dynamic expression
following myocardial injury. Prior studies had identified anti-
apoptotic effects of FSTL1 following ischemia-reperfusion injury
in themyocardium (Ogura et al., 2012; Oshima et al., 2008). In the
context of MI, application of an epicardial patch of FSTL1
following injury significantly improved myocardial proliferation,
survival, and function in mice and swine models (Wei et al.,
2015).
Distinct Role of Neuregulin1 in Development and
Regeneration
NRG1 is a member of the epidermal growth factor family with
crucial roles in cardiac development and homeostatic cardiac
function. Evidence from studies in zebrafish and mice reveals
that signaling through NRG1 and its ERBB receptor tyrosine ki-
nases is crucial for proper heart formation, cardiomyocyte prolif-
eration, and morphology (Hertig et al., 1999; Reischauer et al.,
2014). In zebrafish with erbb2/ cardiomyocytes, myofibril or-
ganization is disrupted due to abnormalities in spatiotemporal
organization along the apico-basal axis of the heart (Reischauer
et al., 2014). In mouse studies in which the effects of NRG1 in
later development were explored, NRG1 signaling is necessary
for trabeculation of the ventricular wall and compact zone
expansion (Hertig et al., 1999). Thus NRG1 plays a major role
in heart development and signaling between endocardium and
myocardium as well as regulating differentiation and maturation
during morphogenesis (Grego-Bessa et al., 2007; Xin et al.,
2013a). In vitro, treatment of rat neonatal cardiomyocytes with
NRG-1 results in increased F-actin organization, proliferation,
protein production, and hypertrophy (Baliga et al., 1999; Rei-
schauer et al., 2014).
The cardiomyocyte mitogenic property of NRG1 in vitro has
motivated studies on a potential role of NRG-1 in cardiac regen-
eration. In injured zebrafish hearts, NRG1 protein expression isDevelopmental Cell 36, February 22, 2016 ª2016 Elsevier Inc. 369
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ing et al., 2015). In uninjured zebrafish hearts, exogenous
expression of Nrg1 promotes cardiomyocyte proliferation and
dedifferentiation. In adult mice, NRG1-mediated activation of
the ERBB2-ERBB4 receptor heterodimer stimulates cardiomyo-
cyte proliferation (Bersell et al., 2009), and transient induction of
a constitutively active ERBB2 receptor was shown to be suffi-
cient to reactivate cardiomyocyte proliferation in adults (D’Uva
et al., 2015). However, another study found no induction of car-
diomyocyte DNA synthesis with neuregulin-1 treatment in injured
mouse hearts (Reuter et al., 2014).
The Hippo Pathway Controls Heart Development and
Regeneration
Cell-intrinsic signaling pathways that regulate cardiomyocyte
proliferation during development have an active role in regen-
eration. The Hippo pathway is an evolutionarily conserved
pathway that regulates organ size and growth during develop-
ment in a range of animals from Drosophila to humans by re-
straining cellular proliferation, inducing apoptosis and regulating
cell fate decisions (Zhao et al., 2011). Mechanical stress, cell po-
larity, cell adhesion, and cell junction proteins activate the Hippo
pathway, which acts through phosphorylation of transcription
co-activators YAP and TAZ in mammals. When the Hippo
pathway is off and YAP/TAZ proteins are dephosphorylated,
they are translocated to the nucleus and induce pro-proliferation
gene expression. The Hippo pathway participates in cardiac
organogenesis in a range of events from progenitor migration
to the midline in early cardiac development (Miesfeld and Link,
2014), to cardiac proliferation (von Gise et al., 2012). Phenotyp-
ical analyses of Hippo pathway mutant mouse models suggest
that disrupting Hippo effectors in cardiomyocyte precursors reg-
ulates proliferation and cell size (Zhou et al., 2015). Moreover,
Hippo signaling interacts with other signaling pathways, such
as Wnt, to orchestrate proliferation and size in the developing
heart (Heallen et al., 2011). Mice that are null for the Hippo
pathway component protein salvador homolog1 (Sav1) (sys-
temic deletion and cardiomyocyte-specific deletion) have
improved heart regenerative capacity and reduced scar size
following adult MI and postnatal day 8 post apical resection,
when control mice have very limited ability to regenerate re-
sected tissue (Heallen et al., 2013). Similar results are obtained
with MI injury in Sav1 KO as well as Yap-overexpressing trans-
genic animals, at ages as old as 1 or 2 months (Xin et al.,
2013b), and enhanced regeneration appears to be due to
enhanced cardiomyocyte proliferation following injury(Heallen
et al., 2013; Xin et al., 2013b). More recently, Lin et al. (2014)
showed that cardiac-specific YAP activation following MI im-
proves cardiac function and leads to better survival, indicating
that repressing the Hippo pathway can enhance regenerative
outcome in adults following injury.
Conclusions
New research in heart regeneration in different experimental
models is revealing that many molecular mechanisms may be
shared by organisms that are able to regenerate their hearts.
These mechanisms include stimulation of an essential immune
response, regulation by extracellular cues, a role for nerves,
and a critical contribution for cardiomyocyte division. We still
do not understand the barriers to heart regeneration that lead370 Developmental Cell 36, February 22, 2016 ª2016 Elsevier Inc.to extensive scarring and eventual heart failure in humans who
havemajor cardiac injuries. The imperative for the field is to learn
from the developmental biology of the heart and define the
regenerative pathways. Currently, after blood flow is restored
in heart attack patients, we largely watch and see how extensive
the injury becomes. In this critical time window, there is an op-
portunity to identify which patients may develop heart failure in
the future and treat them with a regenerative therapy. Should
we deliver exogenous cells to replace the lost cardiomyocytes,
or can we activate endogenous regeneration pathways at just
the right moment?
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